38112003: 1 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
un	Is a	General adjectival modifier	false	Inferred relationship	Some
un	Is a	nombre	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely ticarcillin (as ticarcillin disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Product containing precisely ticarcillin (as ticarcillin disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ticarcillin (as ticarcillin disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Mezlocillin (as mezlocillin sodium) 1 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Mezlocillin (as mezlocillin sodium) 1 g powder for solution for injection vial	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Mezlocillin (as mezlocillin sodium) 1 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely amoxicillin anhydrous (as amoxicillin) 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely amoxicillin anhydrous (as amoxicillin) 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cefaclor anhydrous (as cefaclor) 250 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cefaclor anhydrous (as cefaclor) 250 milligram/1 each conventional release chewable tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely albiglutide 30 milligram/1 pen powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely albiglutide 30 milligram/1 pen powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely ceftizoxime (as ceftizoxime sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ceftizoxime (as ceftizoxime sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Albiglutide 50 mg powder for solution for injection pen	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Albiglutide 50 mg powder for solution for injection pen	Count of base of active ingredient	False	un	Inferred relationship	Some
Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch	Has concentration strength denominator value	False	un	Inferred relationship	Some	3
Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch	Has concentration strength denominator value	False	un	Inferred relationship	Some	2
Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Trastuzumab 440 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Trastuzumab 440 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely plicamycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely plicamycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Varicella-zoster virus antibody 500 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Varicella-zoster virus antibody 500 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Alprostadil 20 microgram/mL solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Alprostadil 20 microgram/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension	Count of base of active ingredient	False	un	Inferred relationship	Some
Cefoxitin (as cefoxitin sodium) 10 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Cefoxitin (as cefoxitin sodium) 10 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely alprostadil 10 microgram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely alprostadil 10 microgram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely dyclonine hydrochloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely dyclonine hydrochloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation	Count of base of active ingredient	False	un	Inferred relationship	Some
Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Sodium chloride 9 mg/mL solution for ocular irrigation	Count of base of active ingredient	False	un	Inferred relationship	Some
Sodium chloride 9 mg/mL solution for ocular irrigation	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Drotrecogin alfa 5 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Drotrecogin alfa 5 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cefaclor anhydrous (as cefaclor) 37.4 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely cefaclor anhydrous (as cefaclor) 37.4 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely levofloxacin anhydrous (as levofloxacin) 15 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely levofloxacin anhydrous (as levofloxacin) 15 milligram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Polymyxin B (as polymyxin B sulfate) 500000 unit powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Polymyxin B (as polymyxin B sulfate) 500000 unit powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 150 microgram/1 pen powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 150 microgram/1 pen powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely nonacog alfa 1000 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely nonacog alfa 1000 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely cefalexin anhydrous (as cefalexin) 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely cefalexin anhydrous (as cefalexin) 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely nonacog alfa 500 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely nonacog alfa 500 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Levofloxacin anhydrous (as levofloxacin) 5 mg/mL eye solution	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Levofloxacin anhydrous (as levofloxacin) 5 mg/mL eye solution	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely streptokinase 1.5 million unit/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely streptokinase 1.5 million unit/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely cefamandole (as cefamandole nafate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Product containing precisely cefamandole (as cefamandole nafate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely cefamandole (as cefamandole nafate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Interferon beta-1a 30 microgram/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Interferon beta-1a 30 microgram/mL solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1

Start Previous Page 200 of 215 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
33081000077110	un	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module